RxDoctor Payments Data

Trisha Folse

Women's Health · Thibodaux, LANPI 1669583688

Payments from drug & device makers

What this record shows

Almost everything reported here is food and beverage — 92.4% of the total across 134 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. It is spread thinly across 22 manufacturers, the largest accounting for just 22.3% — the pattern of someone who eats at a lot of different presentations.

$2,496in general payments, 2019–2025

Across 134 payments — averaging $18.63 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Amgen$556
  • Sumitomo Pharma America, Inc.$310
  • AbbVie$296
  • Exeltis, USA Inc.$257
  • Mayne Pharma Commercial LLC$241
  • Astellas Pharma US Inc$207
  • plus $631 from 16 others

What the payments were for

  • Consulting fees$1757%
  • Food & beverage$2,30792%
  • Education$141%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$2,496 in reported general payments places this provider in the 85th percentile of 128 women's health providers in Louisiana.

See all women's health providers in Louisiana

Medicare billing

Part B allowed, 2024
$29,115
Medicare patients
229
Services billed
576

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
Raloxifene Hcl95$3,857
Estradiol51$2,545
Alendronate Sodium289$2,062
Risedronate Sodium30$1,265
Oxybutynin Chloride ErOxybutynin Chloride14$551
Clotrimazole-BetamethasoneClotrimazole/Betamethasone Dip18$529
ProgesteroneProgesterone, Micronized13$525
Metronidazole16$320
Nitrofurantoin Mono-MacroNitrofurantoin Monohyd/M-Cryst11$139
Fluconazole11$48

Paid to pharmacies, not to this prescriber.

Other women's health in Thibodaux

See the full list for Louisiana

Where these figures come from

Is this you, or does something look wrong? →